Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adial Pharmaceuticals (ADIL) Shares Issued (2022 - 2024)

Adial Pharmaceuticals' Shares Issued history spans 3 years, with the latest figure at $197221.0 for Q4 2024.

  • For Q4 2024, Shares Issued fell 73.7% year-over-year to $197221.0; the TTM value through Dec 2024 reached $4.0 million, up 436.24%, while the annual FY2025 figure was $3.7 million, 9.02% down from the prior year.
  • Shares Issued for Q4 2024 was $197221.0 at Adial Pharmaceuticals, down from $3.4 million in the prior quarter.
  • Across five years, Shares Issued topped out at $18.2 million in Q2 2022 and bottomed at -$9.1 million in Q1 2022.
  • The 3-year median for Shares Issued is $403417.0 (2023), against an average of $477329.3.
  • The largest YoY upside for Shares Issued was 527.33% in 2024 against a maximum downside of 459.95% in 2024.
  • A 3-year view of Shares Issued shows it stood at -$9.1 million in 2022, then skyrocketed by 108.22% to $749885.0 in 2023, then plummeted by 73.7% to $197221.0 in 2024.
  • Per Business Quant, the three most recent readings for ADIL's Shares Issued are $197221.0 (Q4 2024), $3.4 million (Q3 2024), and -$3.4 million (Q2 2024).